Use of Low-Level Laser Therapy as Monotherapy or Concomitant Therapy for Male and Female Androgenetic Alopecia

    January 2014 in “ International Journal of Trichology ”
    Andreia Munck, Maria Fernanda Gavazzoni, Ralph M. Trüeb
    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Low Level Laser Therapy →

    laser therapy for anti-inflammatory and likely insignificant hair regrowth effects

    Image
    Studysummary This study found that low-level laser therapy may improve hair growth in patients with androgenetic alopecia, either as a standalone treatment or combined with minoxidil or finasteride, without reported adverse reactions. Our plain-language summary of this paper — not a Tressless recommendation.
    The study evaluated the use of low-level laser therapy (LLLT) for androgenetic alopecia (AGA) in male and female patients, either as monotherapy or as concomitant therapy with minoxidil or finasteride. The study involved 32 patients, and improvement was observed both with monotherapy and with concomitant therapy. Improvement was seen as early as 3 months and was sustained up to a maximum observation time of 24 months. No adverse reactions were reported. The study concluded that LLLT represents a potentially effective treatment for both male and female AGA, either as monotherapy or concomitant therapy.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results